Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 71.10
+0.20 (0.28%)
Nov 6, 2026, 1:22 PM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 1.01 billion as of November 6, 2026. It is the 34,172nd most valuable company in the world and the 2,053rd biggest in Taiwan. Its market cap has decreased by 5.70% in one year.
Market Cap
1.01B
Enterprise Value
1.02B
Revenue
80.54M
Global Rank
Country Rank
#2,053 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 1.01B, a decrease of -44.67%. That is a compound annual growth rate of -11.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.01B | -1.25% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
| Nov 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.29B |
| DIVA Laboratories | 1.77B |
| Genetics Generation Advancement | 935.66M |
| Kim Forest Enterprise | 769.90M |
| Sofiva Genomics | 708.26M |
| TFBS Bioscience | 614.93M |
| Pharmigene | 406.24M |
| Welgene Biotech | 376.36M |